Independent register of U.S. FDA drug recalls · updated Oct 13, 2026
RxRecalls Get alerts

Class II drug recalls - moderate risk

Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.

14,543 recalls, newest first.

Class II · Moderate risk

Nucala (mepolizumab)

Temperature Abuse; Product stored and shipped outside of labeled storage requirements.

Terminated Temperature excursion Cardinal Health dba Specialty Pharmaceutical Services NDC 0173-0892-42 D-1876-2019
Class II · Moderate risk

Anagrelide Capsules

Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.

Terminated Impurity / degradation Torrent Pharma Inc. NDC 13668-453-01 D-1862-2019
Class II · Moderate risk

Clonidine HCL PF 750 mcg/mL/Prialt PF

Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.

Terminated cGMP deviation Coast Quality Pharmacy, LLC dba Anazao Health D-0598-2020

Recalls by year